<?xml version="1.0" encoding="ISO-8859-1"?>
<entity-relation-data lastUpdate="2023-03-27 17:27:39" record="43450" source="Espacenet">
	<entities>
		<entity ref="Patent43450" type="Patent">
			<semanticIdentifier>brcris::bcdf15ac3a0a4b3f4d01b615c4157ae8</semanticIdentifier>
			<semanticIdentifier>docdb::BR102014027271A2</semanticIdentifier>
			<semanticIdentifier>epodoc::BR102014027271</semanticIdentifier>
			<semanticIdentifier>docdb::BR102014027271A</semanticIdentifier>
			<semanticIdentifier>epodoc::BR20141027271</semanticIdentifier>
			<semanticIdentifier>original::102014027271</semanticIdentifier>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=102014027271"/>
			<field name="identifier.lattes" value="5607209140970880"/>
			<field name="identifier.espacenet" value="102014027271"/>
			<field name="kindCode" value="A2"/>
			<field name="title.espacenet" value="método in vitro de avaliar inibição de calicreínas teciduais humanas, uso e composição farmacêutica"/>
			<field name="title.lattes" value="MÉTODO IN VITRO DE AVALIAR INIBIÇÃO DE CALICREÍNAS TECIDUAIS HUMANAS, USO E COMPOSIÇÃO FARMACÊUTICA"/>
			<field name="depositDate" value="2014-10-31"/>
			<field name="publicationDate" value="2018-07-31"/>
			<field name="countryCode" value="BR"/>
			<field name="inventor" value="ESTELA MARIS FREITAS MURI"/>
			<field name="inventor" value="JOCELIA PEREIRA DE CARVALHO OLIVEIRA"/>
			<field name="inventor" value="LUCIANO PUZER"/>
			<field name="inventor" value="SERGIO PINHEIRO"/>
			<field name="inventor" value="THALITA GONCALVES BARROS"/>
			<field name="applicant" value="UNIVERSIDADE FEDERAL DO ABC - UFABC"/>
			<field name="applicant" value="UNIVERSIDADE FEDERAL FLUMINENSE"/>
			<field name="classification.ipc">
				<field name="sequence" value="1"/>
				<field name="text" value="A61K31/34AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="34AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="2"/>
				<field name="text" value="A61K38/48AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="38"/>
				<field name="subgroup" value="48AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="3"/>
				<field name="text" value="A61P17/00AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="17"/>
				<field name="subgroup" value="00AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="4"/>
				<field name="text" value="A61P17/06AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="17"/>
				<field name="subgroup" value="06AI"/>
			</field>
			<field name="abstract.espacenet" value="método in vitro de avaliar inibição de calicreínas teciduais humanas, uso e composição farmacêutica. a presente invenção descreve um método de ligação entre receptor e ligante. especificamente, a presente invenção compreende um composto derivado do isomanídeo de formula geral (i) e um método de ligação do referido composto a calicreína.adicionalmente, a presente invenção compreende o uso do referido composto na preparação de um medicamento para o tratamento de de patologias relacionadas ao processo de descamação epidermal. ainda, a presente invenção provê uma composição farmacêutica contendo o referido composto e pelo menos um excipiente farmaceuticamente aceitável. a presente invenção se situa nos campos da bioquímica e farmácia."/>
			<field name="originatesFrom" value="63164957"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102014027271"/>
				<field name="kind" value="A2"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR102014027271"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102014027271"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR20141027271"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="original"/>
				<field name="country" value=""/>
				<field name="number" value="102014027271"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Person29686" type="Person">
			<semanticIdentifier>lattes::5607209140970880</semanticIdentifier>
			<field name="identifier.lattes" value="5607209140970880"/>
			<field name="name" value="Thalita Gonçalves Barros"/>
		</entity>
		<entity ref="OrgUnit23303" type="OrgUnit">
			<semanticIdentifier>brcris::b4e0e2d9cdc0f26db4523380edc59922</semanticIdentifier>
			<field name="name" value="UNIVERSIDADE FEDERAL FLUMINENSE"/>
		</entity>
	</entities>
	<relations>
		<relation fromEntityRef="Patent43450" toEntityRef="Person29686" type="Inventor"/>
		<relation fromEntityRef="Patent43450" toEntityRef="OrgUnit23303" type="Applicant"/>
	</relations>
</entity-relation-data>
